Key result
Diabetes mortality rose despite glycemic improvements in the Samara region, with T2D deaths up ~45%.
Why the study?
Trend analysis of epidemiological and clinical characteristics of diabetes mellitus patients in the Samara region during the initial spread of COVID-19 can help assess medical care effectiveness and guide improvements.
Observational (n=118,623)
This epidemiological study highlights increasing mortality and changing glycemic control trends among diabetes patients in the Samara region during the initial COVID-19 pandemic period, with cardiovascular disease remaining the leading cause of death.
Answers are grounded in this paper and cite their sources.
Rising diabetes mortality in Samara 2018-2020 despite better control; leaves open pandemic or regional drivers in this observational cohort.
According to domestic and foreign studies, diabetes mellitus (DM) is a significant risk factor for infection with the SARS-CoV-2 virus, a severe course of the disease, and an adverse outcome. Trend analysis of epidemiological and clinical characteristics of DM patients living in the Samara region in the initial period of the spread of the new coronavirus infection can help to assess the effectiveness of medical care for DM patients in a challenging epidemiological setting and to determine the directions for its improvement. Objective. To assess the trends in the prevalence, incidence, and mortality of DM patients living in the Samara region and to identify the changes in the structure of vascular complications and the status of glycemic control from 2018 to 2020. Material and methods. The study of the medical and epidemiological DM indicators was performed according to the design of a continuous retrospective observational study covering the period from 2018 to 2020; the object was the adult population of the Samara region. Results. The total number of DM patients in the Samara region in 2020 was 118.623 people (3.73% of the population), of which type 1 diabetes was detected in 5.2% (6118 people) and type 2 diabetes in 94.2% (111.700 people). The trends of the prevalence of type 1 DM were 186.3→192.4/100.000 population, type 2 DM 3132.5→3153.1/100.000 population; the dynamics of primary morbidity with type 1 diabetes mellitus 8.8→6.2/100.000 population, with type 2 DM 259.1→196.4/100.000 population; mortality with type 1 diabetes mellitus 3.2→4.2/100.000 population, with type 2 diabetes mellitus 120.7→174.5/100.000 population. The most common causes of death were cardiovascular diseases: 30.3% in type 1 DM, 39.7% in type 2 DM; there is a trend towards increasing in death «from DM» without indicating the immediate cause of death for both types of DM; «from COVID-19» 3.8% with type 1 DM and 3.7% with type 2 DM. The incidence of vascular complications in type 1 and type 2 DM was 31.4% and 11.5% for retinopathy, and 21.4 and 11.5% for nephropathy, respectively. Trends in the proportion of patients with HbA1c <7%: 28.1%→51.1% in type 1 DM, 15.7%→62.4% in type 2 DM; with HbA1c ≥9.0%: 25.4%→12.1% in type 1 DM, 39.8%→7.1% in type 2 DM. Conclusion. The study demonstrates the importance of a comparative sequential assessment of the epidemiological characteristics of diabetes mellitus and the clinical status of patients living in the Samara region in challenging epidemiological settings to assess the prospects for optimizing follow-up.
No takes yet. Share an insight, caveat, or question.
Pervyshin et al. (2023) conducted an observational in Diabetes mellitus (n=118,623). Time period (2018-2020) was evaluated on Trends in prevalence, incidence, and mortality. From 2018 to 2020 in the Samara region, mortality increased for type 1 and type 2 diabetes, while the proportion of patients with HbA1c <7% improved.
Synapse has enriched 10 related papers. Consider them for comparative context: